Inventor · disambiguated record
Jens Niewoehner
Also filed as: NIEWOEHNER JENS
25 granted patents·20 pending applications·81 citations·filing 2007–2025
95Inventor score
Files withHOFFMANN LA ROCHE31BAEHNER MONIKA4KNOETGEN HENDRIK2PROTHENA BIOSCIENCE LTD2U3 PHARMA GMBH2
Top patents by PatentIndex Score
45 records- 0197US10323089B2Anti-transferrin receptor antibodies with tailored affinityHOFFMANN LA ROCHE·Filed 2017·Granted Jun 18, 2019·25 cites·9 claims
- 0295US11584793B2Anti-transferrin receptor antibodies with tailored affinityHOFFMANN LA ROCHE·Filed 2019·Granted Feb 21, 2023·8 cites·20 claims
- 0394US12252533B2Anti-transferrin receptor antibodies with tailored affinityHOFFMANN LA ROCHE·Filed 2022·Granted Mar 18, 2025·1 cites·11 claims
- 0493US11098338B2Recombinant polypeptide production methodsHOFFMANN LA ROCHE·Filed 2019·Granted Aug 24, 2021·6 cites·4 claims
- 0591US10822402B2Humanized anti-tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Granted Nov 3, 2020·4 cites·12 claims
- 0689US10806795B2Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttlesHOFFMANN LA ROCHE·Filed 2019·Granted Oct 20, 2020·3 cites·17 claims
- 0789US10370692B2Recombinant polypeptide production methodsHOFFMANN LA ROCHE·Filed 2014·Granted Aug 6, 2019·6 cites·10 claims
- 0889US10364292B2Monovalent blood brain barrier shuttle modulesHOFFMANN LA ROCHE·Filed 2016·Granted Jul 30, 2019·10 cites·10 claims
- 0985US11273223B2Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttlesHOFFMANN LA ROCHE·Filed 2020·Granted Mar 15, 2022·1 cites·28 claims
- 1085US9862763B2Humanized anti-tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2016·Granted Jan 9, 2018·4 cites·13 claims
- 1184US12297263B2Humanized anti-Tau(PS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2022·Granted May 13, 2025·0 cites·6 claims
- 1282US10561737B2Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttlesHOFFMANN LA ROCHE·Filed 2014·Granted Feb 18, 2020·4 cites·17 claims
- 1381US12129306B2Antibodies binding to STEAP-1HOFFMANN LA ROCHE·Filed 2023·Granted Oct 29, 2024·0 cites·1 claims
- 1481US11180571B2Antibodies binding to STEAP-1HOFFMANN LA ROCHE·Filed 2019·Granted Nov 23, 2021·1 cites·31 claims
- 1580US8093006B2Antibodies against human tweak and uses thereofBAEHNER MONIKA·Filed 2010·Granted Jan 10, 2012·4 cites·10 claims
- 1678US9284379B2FGFR4 antibodiesU3 PHARMA GMBH·Filed 2013·Granted Mar 15, 2016·2 cites·18 claims
- 1776US12331134B2Trispecific antibodies specific for HER2 and a blood brain barrier receptor and methods of useHOFFMANN LA ROCHE·Filed 2022·Granted Jun 17, 2025·0 cites·19 claims
- 1875US11685790B2Antibodies binding to STEAP-1HOFFMANN LA ROCHE·Filed 2021·Granted Jun 27, 2023·0 cites·1 claims
- 1972US11572404B2Humanized anti-Tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2020·Granted Feb 7, 2023·0 cites·6 claims
- 2071US2025154249A1Anti-transferrin receptor antibodies with tailored affinityHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 2168US2025034538A1Fusion proteins targeted to the central nervous systemHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2268US2025051429A1Anti-a-beta protein antibodies, methods and uses thereofHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2367US2020299407A1Trispecific antibodies specific for her2 and a blood brain barrier receptor and methods of useHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 2467US2022211865A1Reduction of application-related side reaction of a therapeutic antibodyHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2566US2025163173A1Monovalent blood brain barrier shuttle modulesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 2664US2018291110A1Trispecific antibodies specific for her2 and a blood brain barrier receptor and methods of useHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 2761US10562973B2Blood-brain barrier shuttles containing antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCE LTD·Filed 2015·Granted Feb 18, 2020·1 cites·40 claims
- 2859US2018344869A1Reduction of application-related side reaction of a therapeutic antibodyHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2958US8394927B2FGFR4 antibodiesBANGE JOHANNES·Filed 2007·Granted Mar 12, 2013·1 cites·15 claims
- 3058US2020289665A1Reduction of application-related side reaction of a therapeutic antibodyHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 3157US8883976B2Antibodies against human tweak and uses thereofBAEHNER MONIKA·Filed 2012·Granted Nov 11, 2014·0 cites·4 claims
- 3256US2022098305A1Novel icos antibodies and tumor-targeted antigen binding molecules comprising themHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3356US2020071413A1Monovalent blood brain barrier shuttle modulesHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 3455US8852887B2Antibodies against human tweak and uses thereofBAEHNER MONIKA·Filed 2011·Granted Oct 7, 2014·0 cites·16 claims
- 3552US2020299397A1Blood-Brain Barrier Shuttles Containing Antibodies Recognizing Alpha-SynucleinPROTHENA BIOSCIENCE LTD·Filed 2020·Application pending·0 cites
- 3649US2019276530A1Blood brain barrier shuttleHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 3746US9187564B2Antibodies against human TWEAK and uses thereofBAEHNER MONIKA·Filed 2011·Granted Nov 17, 2015·0 cites·11 claims
- 3845US2015152193A1Axl antibodiesU3 PHARMA GMBH·Filed 2014·Application pending·0 cites
- 3945US2016168253A1Therapeutic fusion proteinHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 4043US2012282176A1Method and Constructs for the pH Dependent Passage of the Blood-brain-barrierBOHRMANN BERND·Filed 2012·Application pending·0 cites
- 4142US2017174776A1METHOD AND CONSTRUCTS FOR THE pH DEPENDENT PASSAGE OF THE BLOOD-BRAIN-BARRIERROCHE GLYCART AG·Filed 2015·Application pending·0 cites
- 4241US8207307B2Antibodies against human CCN1 and uses thereofKNOETGEN HENDRIK·Filed 2010·Granted Jun 26, 2012·0 cites·6 claims
- 4338US2015322149A1Blood brain barrier shuttleHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 4436US2012020988A1Antibodies specifically binding to human TSLPR and methods of useAUER JOHANNES·Filed 2011·Application pending·0 cites
- 4536US2012258112A1Antibodies against human ccn1 and uses thereofKNOETGEN HENDRIK·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jens Niewoehner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →